TC2N transcription was significantly higher in cholangiocarcinoma (CHOL), ovarian serous cystadenocarcinoma (OV), rectal adenocarcinoma (READ), stomach adenocarcinoma (STAD) and thymoma (THYM) (Figure 1A, Figure 1B). This evidence concerns the gene TC2N and cholangiocarcinoma.